derivativo original de Ácido fenilacÉtico
A compound represented by the formula (1) or a salt thereof ( --- represents a single bond, or a double bond; R 1 represents hydrogen atom, or an alkyl group; R 2 and R 3 represent hydrogen atom, or an alkyl group; R 4 and R 5 represent hydrogen atom, hydroxy group, an alkoxyl group, a halogen atom,...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | por |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | JUNICHIRO UDA TUTOMU INOUE HIDEO KATO NOBUHIDE KAWASAKI YOSHIYUBI IWABUCHI TOMOHIKO ISHIKAWA OSAMU NAGATA NAOKI KURITA HIROSHI NAKAMURA TAKAHIRO SATO IPPEI TANAKA |
description | A compound represented by the formula (1) or a salt thereof ( --- represents a single bond, or a double bond; R 1 represents hydrogen atom, or an alkyl group; R 2 and R 3 represent hydrogen atom, or an alkyl group; R 4 and R 5 represent hydrogen atom, hydroxy group, an alkoxyl group, a halogen atom, or a mono- or di-alkyl-substituted amino group; R 6 represents hydrogen atom, cyano group, an alkoxycarbonyl group, or carboxy group; R 7 represents one or two of substituents on the benzene ring (the substituents are selected from hydrogen atom, a halogen atom, nitro group, cyano group, hydroxy group, amino group, an alkyl group, and an alkoxyl group); A represents a 5-membered or 6-membered non-aromatic heterocyclic ring containing one or two contiguous sulfur atoms (the sulfur atoms may independently form oxide); W --- represents oxo group, hydrogen atom, an alkyl group, hydroxy group, an alkoxyl group, or a halogen atom; and X represents oxygen atom, or sulfur atom), or a salt thereof, which has a superior suppressing action against prostaglandin E 2 production and is useful as an active ingredient of medicaments with reduced adverse reactions such as gastrointestinal disorders. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BRPI0716550A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BRPI0716550A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BRPI0716550A23</originalsourceid><addsrcrecordid>eNrjZNBOSS3KLEssySzLV8gvykzPzEvMUUhJVTjcmJyZkq-QlpqXmZOYfLizJDM5n4eBNS0xpziVF0pzMyi5uYY4e-imFuTHpxYXJCan5qWWxDsFBXgamBuamZoaOBoZE6UIAEBxK2s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>derivativo original de Ácido fenilacÉtico</title><source>esp@cenet</source><creator>JUNICHIRO UDA ; TUTOMU INOUE ; HIDEO KATO ; NOBUHIDE KAWASAKI ; YOSHIYUBI IWABUCHI ; TOMOHIKO ISHIKAWA ; OSAMU NAGATA ; NAOKI KURITA ; HIROSHI NAKAMURA ; TAKAHIRO SATO ; IPPEI TANAKA</creator><creatorcontrib>JUNICHIRO UDA ; TUTOMU INOUE ; HIDEO KATO ; NOBUHIDE KAWASAKI ; YOSHIYUBI IWABUCHI ; TOMOHIKO ISHIKAWA ; OSAMU NAGATA ; NAOKI KURITA ; HIROSHI NAKAMURA ; TAKAHIRO SATO ; IPPEI TANAKA</creatorcontrib><description>A compound represented by the formula (1) or a salt thereof ( --- represents a single bond, or a double bond; R 1 represents hydrogen atom, or an alkyl group; R 2 and R 3 represent hydrogen atom, or an alkyl group; R 4 and R 5 represent hydrogen atom, hydroxy group, an alkoxyl group, a halogen atom, or a mono- or di-alkyl-substituted amino group; R 6 represents hydrogen atom, cyano group, an alkoxycarbonyl group, or carboxy group; R 7 represents one or two of substituents on the benzene ring (the substituents are selected from hydrogen atom, a halogen atom, nitro group, cyano group, hydroxy group, amino group, an alkyl group, and an alkoxyl group); A represents a 5-membered or 6-membered non-aromatic heterocyclic ring containing one or two contiguous sulfur atoms (the sulfur atoms may independently form oxide); W --- represents oxo group, hydrogen atom, an alkyl group, hydroxy group, an alkoxyl group, or a halogen atom; and X represents oxygen atom, or sulfur atom), or a salt thereof, which has a superior suppressing action against prostaglandin E 2 production and is useful as an active ingredient of medicaments with reduced adverse reactions such as gastrointestinal disorders.</description><language>por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130924&DB=EPODOC&CC=BR&NR=PI0716550A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25551,76302</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130924&DB=EPODOC&CC=BR&NR=PI0716550A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JUNICHIRO UDA</creatorcontrib><creatorcontrib>TUTOMU INOUE</creatorcontrib><creatorcontrib>HIDEO KATO</creatorcontrib><creatorcontrib>NOBUHIDE KAWASAKI</creatorcontrib><creatorcontrib>YOSHIYUBI IWABUCHI</creatorcontrib><creatorcontrib>TOMOHIKO ISHIKAWA</creatorcontrib><creatorcontrib>OSAMU NAGATA</creatorcontrib><creatorcontrib>NAOKI KURITA</creatorcontrib><creatorcontrib>HIROSHI NAKAMURA</creatorcontrib><creatorcontrib>TAKAHIRO SATO</creatorcontrib><creatorcontrib>IPPEI TANAKA</creatorcontrib><title>derivativo original de Ácido fenilacÉtico</title><description>A compound represented by the formula (1) or a salt thereof ( --- represents a single bond, or a double bond; R 1 represents hydrogen atom, or an alkyl group; R 2 and R 3 represent hydrogen atom, or an alkyl group; R 4 and R 5 represent hydrogen atom, hydroxy group, an alkoxyl group, a halogen atom, or a mono- or di-alkyl-substituted amino group; R 6 represents hydrogen atom, cyano group, an alkoxycarbonyl group, or carboxy group; R 7 represents one or two of substituents on the benzene ring (the substituents are selected from hydrogen atom, a halogen atom, nitro group, cyano group, hydroxy group, amino group, an alkyl group, and an alkoxyl group); A represents a 5-membered or 6-membered non-aromatic heterocyclic ring containing one or two contiguous sulfur atoms (the sulfur atoms may independently form oxide); W --- represents oxo group, hydrogen atom, an alkyl group, hydroxy group, an alkoxyl group, or a halogen atom; and X represents oxygen atom, or sulfur atom), or a salt thereof, which has a superior suppressing action against prostaglandin E 2 production and is useful as an active ingredient of medicaments with reduced adverse reactions such as gastrointestinal disorders.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBOSS3KLEssySzLV8gvykzPzEvMUUhJVTjcmJyZkq-QlpqXmZOYfLizJDM5n4eBNS0xpziVF0pzMyi5uYY4e-imFuTHpxYXJCan5qWWxDsFBXgamBuamZoaOBoZE6UIAEBxK2s</recordid><startdate>20130924</startdate><enddate>20130924</enddate><creator>JUNICHIRO UDA</creator><creator>TUTOMU INOUE</creator><creator>HIDEO KATO</creator><creator>NOBUHIDE KAWASAKI</creator><creator>YOSHIYUBI IWABUCHI</creator><creator>TOMOHIKO ISHIKAWA</creator><creator>OSAMU NAGATA</creator><creator>NAOKI KURITA</creator><creator>HIROSHI NAKAMURA</creator><creator>TAKAHIRO SATO</creator><creator>IPPEI TANAKA</creator><scope>EVB</scope></search><sort><creationdate>20130924</creationdate><title>derivativo original de Ácido fenilacÉtico</title><author>JUNICHIRO UDA ; TUTOMU INOUE ; HIDEO KATO ; NOBUHIDE KAWASAKI ; YOSHIYUBI IWABUCHI ; TOMOHIKO ISHIKAWA ; OSAMU NAGATA ; NAOKI KURITA ; HIROSHI NAKAMURA ; TAKAHIRO SATO ; IPPEI TANAKA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BRPI0716550A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2013</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>JUNICHIRO UDA</creatorcontrib><creatorcontrib>TUTOMU INOUE</creatorcontrib><creatorcontrib>HIDEO KATO</creatorcontrib><creatorcontrib>NOBUHIDE KAWASAKI</creatorcontrib><creatorcontrib>YOSHIYUBI IWABUCHI</creatorcontrib><creatorcontrib>TOMOHIKO ISHIKAWA</creatorcontrib><creatorcontrib>OSAMU NAGATA</creatorcontrib><creatorcontrib>NAOKI KURITA</creatorcontrib><creatorcontrib>HIROSHI NAKAMURA</creatorcontrib><creatorcontrib>TAKAHIRO SATO</creatorcontrib><creatorcontrib>IPPEI TANAKA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JUNICHIRO UDA</au><au>TUTOMU INOUE</au><au>HIDEO KATO</au><au>NOBUHIDE KAWASAKI</au><au>YOSHIYUBI IWABUCHI</au><au>TOMOHIKO ISHIKAWA</au><au>OSAMU NAGATA</au><au>NAOKI KURITA</au><au>HIROSHI NAKAMURA</au><au>TAKAHIRO SATO</au><au>IPPEI TANAKA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>derivativo original de Ácido fenilacÉtico</title><date>2013-09-24</date><risdate>2013</risdate><abstract>A compound represented by the formula (1) or a salt thereof ( --- represents a single bond, or a double bond; R 1 represents hydrogen atom, or an alkyl group; R 2 and R 3 represent hydrogen atom, or an alkyl group; R 4 and R 5 represent hydrogen atom, hydroxy group, an alkoxyl group, a halogen atom, or a mono- or di-alkyl-substituted amino group; R 6 represents hydrogen atom, cyano group, an alkoxycarbonyl group, or carboxy group; R 7 represents one or two of substituents on the benzene ring (the substituents are selected from hydrogen atom, a halogen atom, nitro group, cyano group, hydroxy group, amino group, an alkyl group, and an alkoxyl group); A represents a 5-membered or 6-membered non-aromatic heterocyclic ring containing one or two contiguous sulfur atoms (the sulfur atoms may independently form oxide); W --- represents oxo group, hydrogen atom, an alkyl group, hydroxy group, an alkoxyl group, or a halogen atom; and X represents oxygen atom, or sulfur atom), or a salt thereof, which has a superior suppressing action against prostaglandin E 2 production and is useful as an active ingredient of medicaments with reduced adverse reactions such as gastrointestinal disorders.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | por |
recordid | cdi_epo_espacenet_BRPI0716550A2 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | derivativo original de Ácido fenilacÉtico |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T22%3A16%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JUNICHIRO%20UDA&rft.date=2013-09-24&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBRPI0716550A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |